First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sets New 12-Month High – Here’s What Happened

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)’s stock price reached a new 52-week high on Monday . The company traded as high as $258.25 and last traded at $257.6450, with a volume of 6813 shares traded. The stock had previously closed at $255.93.

First Trust NYSE Arca Biotechnology Index Fund Price Performance

The stock has a market capitalization of $2.85 billion, a PE ratio of 21.72 and a beta of 0.66. The firm’s 50 day simple moving average is $240.94 and its 200 day simple moving average is $218.75.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Several institutional investors have recently added to or reduced their stakes in the business. Ocean Park Asset Management LLC purchased a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the second quarter worth about $2,213,000. Wealthcare Advisory Partners LLC bought a new position in First Trust NYSE Arca Biotechnology Index Fund during the 2nd quarter worth approximately $221,000. HF Advisory Group LLC grew its position in First Trust NYSE Arca Biotechnology Index Fund by 5.0% during the 2nd quarter. HF Advisory Group LLC now owns 1,270 shares of the company’s stock worth $315,000 after acquiring an additional 60 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 1,113.3% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,007 shares of the company’s stock worth $250,000 after purchasing an additional 924 shares during the period. Finally, First Heartland Consultants Inc. increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 6.2% in the 2nd quarter. First Heartland Consultants Inc. now owns 3,292 shares of the company’s stock worth $816,000 after purchasing an additional 191 shares during the period.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.